Graves' orbitopathy
Clinical trials for Graves' orbitopathy explained in plain language.
Never miss a new study
Get alerted when new Graves' orbitopathy trials appear
Sign up with your email to follow new studies for Graves' orbitopathy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a cholesterol drug shrink eye muscle swelling in thyroid eye disease?
Disease control Not yet recruitingThis trial tests whether adding atorvastatin, a common cholesterol-lowering drug, to the standard steroid treatment can better reduce eye muscle swelling in people with moderate-to-severe thyroid eye disease. Half of the participants will receive the standard steroid alone, while…
Matched conditions: GRAVES' ORBITOPATHY
Phase 1 • Sponsor: Banu Aji Dibyasakti • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Eye damage in Graves' disease: can early clues predict who is at risk?
Knowledge-focused Not yet recruitingResearchers at the University of Copenhagen are studying why some people with newly diagnosed Graves' disease develop thyroid eye disease while others do not. The study follows about 430 participants for one year, collecting eye exams, blood and tear samples, and symptom question…
Matched conditions: GRAVES' ORBITOPATHY
Sponsor: University of Copenhagen • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC